Editorial

Weight gain on dolutegravir: Association is not the same as causation

Gary Maartens, Phumla Sinxadi, W.D. Francois Venter
Southern African Journal of HIV Medicine | Vol 24, No 1 | a1500 | DOI: https://doi.org/10.4102/sajhivmed.v24i1.1500 | © 2023 Gary Maartens, Phumla Sinxadi, W.D. Francois Venter | This work is licensed under CC Attribution 4.0
Submitted: 31 March 2023 | Published: 15 May 2023

About the author(s)

Gary Maartens, Division of Clinical Pharmacology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
Phumla Sinxadi, Division of Clinical Pharmacology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
W.D. Francois Venter, Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa


Share this article

Bookmark and Share

Abstract

No abstract available.

Keywords

dolutegravir; integrase strand transfer inhibitors; weight gain; obesity; efavirenz

Metrics

Total abstract views: 249
Total article views: 220


Crossref Citations

No related citations found.